Anti SUMO2 polyclonal antibody
應(yīng)用:WB,ICC,IHC?
產(chǎn)品名:Anti SUMO2 polyclonal antibody
貨號:KLP166?
種類(Category)
Primary antibody
宿主(Host)
Rabbit
反應(yīng)種屬(Species specificity)
Human,other species was not test
應(yīng)用實(shí)驗(yàn)(Tested applications)
WB:1:2000~1:8000,ICC:1:50~200,IHC:1:50~100
克隆性(Clonality)
Polyclonal
偶連物(Conjugation)
Unconjugated
免疫原(Immunogen)
Recombinant protein of human SUMO2(Met1-Tyr95).
別名
Small ubiquitin-related modifier 2,Ubiquitin-like protein SMT3B,SUMO2,SUMO-3,SMT3 homolog 2,Smt3B,SUMO-2,SMT3H2,HSMT3,SMT3B,Sentrin-2
狀態(tài)(Form)
Liquid
儲存溶液(Buffer)
PBS,pH7.4,containing 0.05% proclin300,50% glycerol.
存放條件(Storage)
Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
濃度(Concentration)
0.24mg/ml
亞型(Isotype)
IgG
分子量(MW)
11kDa
純化方式(Purity)
Antigen affinity purification
產(chǎn)品背景:Ubiquitin is most famous for its function in targeting proteins for degradation by the 26S proteasome, ubiquitin needs to be attached to a substrate in chains (polyubiquitylation) before being recognized by proteasome. Similarly, SUMO (small ubiquitin-related modifier) can be linked to substrates in chains (polysumoylation), SUMO modification has been implicated in many important cellular processes including the control of genome stability, signal transduction, targeting to and formation of nuclear compartments, cell cycle and meiosis. There are 4 confirmed SUMO isoforms in human, SUMO-1, SUMO-2, SUMO-3 and SUMO-4. SUMO-2 and SUMO-3 are nearly identical but are distinct from SUMO-1. SUMO2/3 conjugation was recently widely involved in neuroprotective activities. A substitution (M55V) of SUMO4 was strongly associated with the pathogenesis of type 1 diabetes (T1D) involving NF kappa B related mechanisms.